By Charlie Jordan, Founder & CEO of VITL
Cash-pay healthcare is a $100 billion market growing at double digits. The physicians in it (med spas, hormone clinics, longevity practices, concierge medicine, direct primary care) are prescribing treatments that are genuinely 10 years ahead of the traditional system.
Their infrastructure is 10 years behind it.
These are the most innovative prescribers in American medicine. They’re pioneering peptide therapies, personalized hormone protocols, and precision weight management with GLP-1s. But the tools available to them (the e-prescribing platforms, the pharmacy portals, the order management systems) were all purpose-built for legacy sick care. Insurance-based. Reactive. Designed for a world of PBMs, retail chains, and formulary lookups.
Cash-pay preventative health doesn’t work that way. The pharmacies are different. The economics are different. The speed is different. And because no one ever built infrastructure for this market, these clinics are manually managing the entire pharmacy experience themselves. Credentialing with five to seven pharmacies individually, tracking whether a prescription was filled, following up on whether it shipped, hunting inventory by phone when a compound goes out of stock, all while trying to ensure their patients actually receive the medications they prescribed. Not because they lack technology, but because the technology that exists wasn’t built for how they practice medicine.
The cost? We’ve measured it. The average clinic loses over $100,000 a year in productivity and inefficiency just managing prescriptions. Physicians are spending two full workdays a month on pharmacy operations instead of patients.
We started VITL to end that.
Why I Built This
I’ve spent my career in digital health, from the earliest days of direct-to-consumer telehealth through some of the largest names in virtual care and locum tenens staffing. What I saw from the inside was the same thing at every stop: ugly, overcomplicated systems making simple things painful. Platforms that added layers of complexity to workflows that should have been effortless. The more advanced the care became, the further behind the technology fell.
That mismatch is what seeded VITL. Not a desire to build another tool, but a conviction that the entire approach was wrong. The clinics pushing medicine forward deserved infrastructure built the way they practice: beautifully simple. Solutions that don’t manage work. They eliminate it. For the clinic, the physician, the care team, and the patient.
What VITL Actually Is
VITL is the operating system for cash-pay health. An open marketplace where clinics compare verified 503A & 503B compounding pharmacies, order from multiple sources in a single transaction, and give patients real-time tracking from prescription to doorstep.
One login replaces seven pharmacy portals. No phone calls. No guessing. No manual follow-up.
Real-time pricing across our entire pharmacy network. Order management across multiple pharmacies in a single workflow. Patients get tracking links. Physicians get their time back.
We launched in late 2024. Less than 18 months later, the traction told us we’d found the nerve.
The Numbers
Today I’m announcing that VITL has raised $7.5M in Series A funding led by SignalFire.
Here’s where we are:
- 700+ clinics on the platform
- 1,000+ active prescribers
- Eight-figure ARR in less than two years from launch
- 90%+ quarter-over-quarter order growth
- Clinics report saving 2 full workdays per month
- Average cost savings: $100,000 per clinic annually
And here’s the part of this story I like telling the most: SignalFire came to us. No pitch deck. No outbound. They found VITL, looked at the traction, and reached out. In a funding environment where founders are grinding through hundreds of investor meetings, we didn’t send a single cold email. The product spoke for itself.
That’s not a brag. It’s a proof point. When a firm like SignalFire, known for their data-driven sourcing, identifies you before you’re fundraising, it validates that the market signal is real and the execution is visible.
Why This Market, Why Now
Three forces are converging that make this moment inevitable.
Patients are leaving the traditional system. Direct primary care, concierge medicine, cash-pay clinics. Consumers are voting with their wallets for transparency, access, and choice. The cash-pay market is the fastest-growing segment of personal healthcare consumption in America.
The regulatory landscape is accelerating demand. FDA enforcement is professionalizing the compounding pharmacy industry. The Novo Nordisk/Hims & Hers deal reshaped GLP-1 distribution overnight. State-level telehealth expansion is creating thousands of new prescribers. Every one of these shifts increases the volume of prescriptions flowing through cash-pay channels and the urgency for infrastructure that can handle it.
Legacy systems were built for sick care, not preventative health. Every major e-prescribing platform on the market today is a SureScripts skin, purpose-built for insurance-based, reactive medicine. They assume a PBM is routing the prescription. They assume a retail pharmacy is dispensing it. They assume the patient’s insurance is paying for it. None of those assumptions hold in cash-pay. You can’t retrofit sick care plumbing for a preventative health economy. You have to build new infrastructure from scratch.
That’s what we did.
What’s Next: Eliminating Clinical Drag
In Formula 1, the difference between winning and losing comes down to drag. Every ounce of unnecessary resistance the car carries. The teams that win aren’t the ones that bolt on more features. They’re the ones that ruthlessly eliminate everything that slows the car down.
That’s how we think about building VITL.
E-prescribing was the first and most obvious source of drag we eliminated. But it’s not the last. Every clinic that runs on our platform still carries friction we haven’t solved yet: how they manage patient programs, how they interact with pharmacy networks, how they handle compliance, how prescriptions flow between systems.
This funding accelerates our roadmap to eliminate all of it. We’re expanding our pharmacy network. We’re building deeper automation into the prescription lifecycle. We’re adding tools for clinical program management and subscription workflows. We’re investing in interoperability that connects VITL to the broader healthcare ecosystem.
The thesis is simple: if it creates drag for a cash-pay clinic and it isn’t treating a patient, we want to remove it. Every workflow, every manual step, every phone call, every redundant credential. All of it.
We’re not building another healthcare tool. We’re building infrastructure that eliminates the need for most of them.
We got here because 630+ clinics bet on something new before it was proven. The next chapter is for the thousands that haven’t yet, and for the millions of patients they serve. The operating system for cash-pay health is being built right now, in Nashville, and this is just the foundation.
